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http://dx.doi.org/10.1016/j.jfma.201Withdrawal from dialysis is ethically appropriate for some patients with multiple comorbidities
and a shortened life expectancy. Taiwan has the highest prevalence of dialysis patients in the
world, and the National Health Insurance (NHI) program offers renal replacement therapy free
of charge. In this review, we discuss its current status and many background issues related to
withdrawing dialysis from patients with advanced renal failure in Taiwan. Compared with dial-
ysis therapy, the medical resources for hospice care are relatively sparse. Since the announce-
ment of the Statute for Palliative Care in 2000, there has been a gradual improvement in the
laws and health polices supporting dialysis withdrawal. Culture and social customs also have a
significant impact on the practice of hospice care. Based on current evidence and in accor-
dance with the local environment, we propose recommendations for the clinical practice of
dialysis withdrawal and hospice care. There remains a need to expand upon the community-
based hospice care and home care systems to better serve patients. In conclusion, there areiwan University Hospital Jin-Shan Branch, Number 51, Nanshi, Jinshan District, New Taipei City 208,
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590 C.-F. Lai et al.cross-cultural differences relating to dialysis withdrawal between Taiwan and Western coun-
tries. Our experience and clinical recommendations may be helpful for the countries with
NHI systems or for the Eastern countries.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Case presentation
Mr L was a 53-year-old Taiwanese man with end-stage
renal disease (ESRD) due to hypertensive nephrosclerosis.
He suffered from polio as a child, which made his right leg
flaccid and atrophied. He had a history of a perforated
gastric ulcer and received subtotal gastrectomy with
Billroth II anastomosis as well as coronary artery disease
for which he had undergone a coronary artery bypass
graft. He lived with his parents and had not married. In
the past year, his daily activities had been restricted to his
bed and wheelchair. He underwent hemodialysis due to
uremic symptoms and oliguria 5 months before his final
admission.
Refractory poor appetite, frequent vomiting, and
malnutrition gradually developed over 2 months. He
rejected our suggestion of further examinations, including
endoscopy. Following 1 week of a productive cough, he
developed dyspnea and was physically weak even when at
rest. After hospitalization, an intra-abdominal tumor (sus-
pected gastric cancer) with multiple metastases to the
liver, left adrenal gland, omentum, lymph nodes, and chest
wall was found, complicated by pneumothorax and massive
pleural effusion in the left chest. Treatments included
pleurocentesis, oxygen therapy, and pain control, which
made him much more comfortable. After these treatments,
he requested dialysis withdrawal. He was still mentally
competent and fully comprehended the consequence of
dialysis withdrawal. His Charlson Comorbidity Index score
was 11, and his Karnofsky Performance Status score was 20.
At that time, none of his health-care providers would have
been surprised if had he died in the next 6e12 months. We
recognized that he had a malignancy, multiple severe
comorbidities, and poor functional and nutritional status.
Therefore, we arranged a multidisciplinary team to
approach and discuss the situation with the patient and his
family.
A shared decision-making process with the patient and
his family was launched. After our explanations, he un-
derstood his medical conditions and prognosis. He did not
want to receive hemodialysis or other life-supporting
treatments. His wishes were to stay in his room, have
family by his side, be cared for with kindness, and to die
with dignity in his home. Initially, his family did not agree,
but they ultimately agreed to his wishes. His advance di-
rectives for dialysis withdrawal and hospice care were
made and supported by the medical team and his family. He
was discharged from the hospital without further scheduled
dialysis therapy. Our medical team visited the patient at his
home and gave medications for pain and dyspnea during the
postwithdrawal period. He passed away at home 11 days
after the dialysis withdrawal. According to his mother’s
statement, the patient said “thank you” to her the daybefore his death, words that had not been expressed in
years.Current demands of hospice care for patients
with ESRD in Taiwan
Patients under dialysis, especially elderly patients, have
increased mortality risk. Reports from the United States
show that the all-cause mortality rate in dialysis patients is
1.5, 2.3, and 3.5 times higher than that in age-matched
patients with cancer, heart failure, and diabetes, respec-
tively.1 The 1-year survival rate after dialysis is only 59e75%
in patients older than 75 years.1,2 Advanced age, low serum
albumin levels, nonambulatory status, congestive heart
failure, being underweight, and a number of other comor-
bidities are risk factors associated with increased mortality
in elderly dialysis patients.3 The so-called nursing home
ESRD syndrome is another example; beginning dialysis in
elderly nursing home residents with ESRD is found to be
associated with rapid functional decline and significant
mortality.4 As a result, for those with multiple comorbid-
ities, high symptom burden, and a shortened life expec-
tancy, there is a need to offer a hospice care option that
withdraws life-sustaining treatments.5,6
Since the implementation of the National Health Insur-
ance (NHI) program in 1995, patients with ESRD in Taiwan
are eligible for any type of renal replacement therapy free
of charge and without a co-payment. The NHI program in
Taiwan has facilitated the growth of the dialysis popula-
tion.7 Since 2001, Taiwan has been at the top of the list
regarding dialysis prevalence and incident rates of the
dialysis population in the world.1,8 Although the incidence
rate of dialysis patients is decreasing in Taiwan,9 the
prevalence rate is still increasing.10 In 2009, nearly one-
fifth of the dialysis population in Taiwan consisted of
elderly patients aged 75 years or older.9 Comorbidities of
hypertension, diabetes, depression, congestive heart fail-
ure, ischemic heart disease, peripheral artery occlusive
disease, dyslipidemia, and bacterial colonization were
common in this population.11e16 One recent investigation
showed that among 30,271 ventilator-dependent patients
in Taiwan, 4802 (15.9%) patients also required long-term
dialysis.17 Theoretically, the demand for palliative care in
the dialysis population should be high.
Cessation of dialysis occurs frequently and has been
recognized as an appropriate treatment option in Western
countries.1,18e21 Dialysis withdrawal is the second or third
leading cause of death in patients with ESRD in North
America and Australia.1,18 However, of those who with-
draw, only approximately 40% use hospice care.20 This un-
derutilization of hospice in dialysis patients may be more
severe in Asian countries because related reports from this
Figure 1 Disparity in resources for dialysis therapy and
hospice care in Taiwan. (A) Distribution of dialysis and hospice
resources in Taiwan. Data were assessed from the Taiwan So-
ciety of Nephrology and Hospice Foundation of Taiwan in
September 2012. D Z dialysis therapy facility; H Z hospice
care facility. (B) National data on the numbers of and services
offered by facilities for dialysis therapy and hospice care.
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withdrawal has previously been reported to be extremely
low in Japan.24 However, 55e82% of ESRD patients in Japan
prefer dialysis withdrawal and do not resuscitate (DNR)
orders when facing terminal cancer or dementia.25 In
Taiwan, there is a great disparity between the resources for
dialysis therapy and hospice care (Fig. 1). There has been
no formal statistical report addressing dialysis withdrawal
in Taiwan until now. This reflects the lack of consensus
about this issue in the medical community and also in the
general population. Table 1 shows important barriers to
hospice care and withdrawing dialysis for patients with
advance renal failure in Taiwan. Fortunately, the
nephrology community now devotes attention to the issue
of medical futility and emphasizes the importance of
palliative care for the dialysis population. Clinical practice
guidelines for physicians for withholding and withdrawing
dialysis in Taiwan are currently being developed.26,27Ethical issues regarding dialysis withdrawal
The principle of autonomy (self-determination) is implicit
in informed consent.28 A competent patient has a moral and
legal right to cease treatment when he or she desires to do
so. This is especially important when unwanted medical
interventions prolong the dying process. Furthermore,patient autonomy is not the only important factor for
dialysis decision-making.29 For a specific group of patients
with ESRD, more harm than good is gained from dialysis.
Considering the principles of beneficence (to maximize
good) and nonmaleficence (first do no harm),28 to continue
dialysis is to prolong pain and suffering, which contradicts
medical ethics. Futile dialysis also imposes unjustified
financial burdens on the health-care system.30,31
Withdrawing treatment can often be more difficult than
withholding treatment.32 For family members, withdrawing
dialysis is not an easy decision because they feel respon-
sible for actively causing an event that will lead to their
loved one’s death. According to the principle of autonomy
and the doctrine of double effect,33 there is no ethical
difference between withholding and withdrawing life-
sustaining treatment.34 With informed consent and shared
decision making, withdrawal from dialysis is ethically and
clinically acceptable.Law and health policy in Taiwan
The Statute for Palliative Care was enacted and promul-
gated in June 2000. This statute respects the wishes of
terminally ill patients and provides the right to receive
hospice care and to issue a DNR order. This made Taiwan
the first nation in Asia to legally safeguard the right of
“dying well” for terminally ill patients. A terminal patient
may choose to undergo hospice care and sign a letter of
intent. Two or more people of full capacity should witness
the patient signing the letter of intent. However, affiliated
personnel of the medical institution supplying hospice care
shall not serve as witnesses. In December 2002, the first
amendment enabled the termination or removal of car-
diopulmonary resuscitation in eligible terminally ill pa-
tients. The second amendment made in January 2011
specifies the provisions regarding the withdrawal of car-
diopulmonary resuscitation. In January 2013, a legislation
specifying the terms of life-supporting treatments and
choice has been implemented in the third amendment. The
provisions regarding cardiopulmonary resuscitation or life-
supporting treatments withdrawal were revised: it requires
only one closest family member to agree on withdrawing
resuscitation and life support from an incompetent patient.
Since 2007, individuals who are willing to accept hospice
care can register that information in the NHI database. The
NHI database contains health-care data on >99% of the
entire population in Taiwan and covers all inpatient and
outpatient medical benefit claims. The NHI integrated cir-
cuit (IC) card is needed for almost all medical care in
Taiwan. Hospice care registration information can be
electronically entered in the NHI IC card, helping medical
workers know immediately, should the situation arise,
whether patients will likely agree to hospice care. This
registration was specified in the 2011 amendment of the
Statute for Palliative Care, which officially introduced the
concept of advance care planning (ACP) into the law.
In September 2009, the bureau of the NHI amended the
fee-charging standard to expand inpatient hospice care to
terminally ill patients who do not have cancer. Patients
with acute or chronic renal failure, including ESRD, were
included as candidates for noncancer hospice care
Table 1 Important barriers to hospice care and withdrawing dialysis for patients with advance renal failure in Taiwan.
Patient-
related
Patient and family Variations in goals and values, lack of information about hospicea, lack of efficient
communication with physiciansa
ACP Lack of ACPa, lack of medical proxya
Physician-
related
Concept of withdrawing Medical ethics uncertaintya, not familiar with the law and regulationsa, fear of legal
issues, discomfort with end-of-life issues
ACP and hospice care Lack of traininga, time-consuming process for ACP
Execution Difficulty in prognosticating survivala, lack of consensus among physiciansa, not
knowing how to starta
System-
related
Legal statutes Rigorous provisions in withdrawing life-supporting treatments from incompetent
patients
ACP Not addressing preferences for dialysisa, identifying ACP in emergencya
Medical care system Transitions of care, lack of community-based hospice care systemsa
Culture and social custom See Table 3
Religious See Table 3
Finance National health insurance in Taiwan does not require co-payment for dialysis
ACP Z advance care planning.
a Modifiable factors: refer to the text for potential solutions.
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gram of the NHI was released and executed beginning in
April 2011. As a result, hospice care and foregoing dialysis
for patients with renal failure are supported by the laws
and health policies in Taiwan.Impacts of culture and social customs on
hospice care in dialysis patients
Culture and social customs in Taiwanmake the use of hospice
care a different experience than that encountered in West-
ern countries (Table 3). Unlike the autonomy that prevails in
Western culture, interdependence of the family during de-
cision making is often more valued in Chinese culture.35Table 2 Criteria for hospice care in patients with terminal ren
Acute renal failure
1) The patient has received renal replacement therapy
(hemodialysis, peritoneal dialysis, kidney transplant)
2) The patient is expected to die in the near future due to the se
care team
3) The patient is unwilling to receive long-term dialysis or a kid
made in clear consciousness, or dialysis is not suitable due t
(i) Other organ failure and life-threatening complications;
(ii) Long-term ventilator dependence;
(iii) Serious infectious disease with various life-threatening co
(iv) Cachexia or severe life-threatening malnutrition;
(v) Malignancy in the terminal stage;
(vi) Life-threatening conditions in a patient who is extremely
elderly or has another systemic disease.Family members frequently become the primary decision
makers in Taiwan, especially in cases involving elderly pa-
tients. There may be conflict regarding the treatment plan
between the patient and family, and physicians are likely to
follow the family’s decision. When considering dialysis
withdrawal and hospice, health-care providers should
respect this family-centered model even when the patient is
competent or in the presence of advance directives. It is
recommended that family members be included in kidney
care from the beginning, which may include arranging
frequent family meetings, disclosing information before
each decision, and coordination while making decisions.35
Another important issue is that many Taiwanese view
the disclosure of bad news as dangerous to the patient.36
Family may discourage physicians from delivering aal failure in the regulation in Taiwan.
Chronic renal failure
1) The patient has advanced chronic kidney disease
(stage 4, 5, or end-stage kidney disease) with or without
renal replacement therapy (hemodialysis, peritoneal
dialysis, kidney transplant)
vere symptoms of uremia found in the assessment by the renal
ney transplant, according to his (or her) autonomous decision
o the coexistence of one of the following conditions:
mplications;
dependent on another’s full-time care because the patient is
Table 3 Special cultural considerations in Taiwan relating to renal hospice care.
Phenomenon Potential solutions
Family-centered decision-making model C Respect this model
C Include family members early in kidney disease care. Assess
decision-making and communication styles. Identify the
major decision makers
C Repeat family meetings
C Comply with the provisions of the Statute for Palliative Care
The family discourages disease disclosure
to the patient
C Negotiate first, and then encourage information sharing
with the patient
C Show the evidence of the beneficial effects of disease
disclosure to the patient
Children are reluctant to discuss with their
parents about hospice care because of filial piety
C Promote ACP to the general population
C Encourage truth telling and shared decision-making
The general population is unfamiliar with
the considerations in decision making
for life-sustaining treatment
C Educational programs with hypothetical scenarios
Traditional belief in life-after-death and the
wish for a natural death
C Utilize this belief to support hospice care in terminally
ill patients
Going home to die C Community-based hospice care services
Medical dispute C Family meetings and shared decision-making process before
each medical decision is made
ACP Z advance care planning.
Dialysis withdrawal in Taiwan 593disease diagnosis or prognostic information to the pa-
tient.37,38 This not only prevents the possibility of making
ACP but also ignores the patient’s right to self-
determination. Insistence on the Western autonomy-based
approach will erode the values of the Taiwanese cultural
background. In this situation, we recommend negotiating
with the family first and then encouraging them to share
the information with the patient during the shared
decision-making process. Experiences from hospice care for
cancer patients in Taiwan have shown that disease disclo-
sure to the patients themselves can improve the patients’
hope and the quality of pain control for the patients.37,38
Informing the family of the evidence for the beneficial ef-
fects of sharing this information may help to achieve better
hospice care.39
Furthermore, most patients and families in Taiwan are
unfamiliar with the considerations for initiating the life-
sustaining treatments or withdrawal; what induces doctors
to suggest hospice care may not be the same as what the
general population would prefer.40 Hypothetical scenarios
havebeenused toenhance theunderstandingof thedecision-
making process in elderly Chinese populations.41 One recent
study used hypothetical scenarios to investigate attitudes
toward dialysiswithdrawal in nephrologists, dialysis patients,
families, and the general population in Taiwan. They were
most likely to agree to withdraw dialysis with the occurrence
of severe infectious complications, long-term ventilator
dependence, and multiple organ failure.27 Given similar sit-
uations, shared decision making is recommended to reach
consensus and preserve a better quality of life in Taiwan.In Chinese culture, dying at home has a special mean-
ing and is considered to be the most glorious and fortu-
nate manner of death.42 However, our previous study of
critically ill patients in Taiwan showed that patients were
only taken home to die at very late stages of illness.43
Going home to die in Taiwan may represent a cultural
tradition and not necessarily be a form of hospice care.
Reports from the United States show that patients
receiving hospice care after dialysis withdrawal were
more likely to die at home, with their families present,
and have a good quality of death.20,44,45 There is also a
need to develop a local, community-based hospice care
system in Taiwan.Education for hospice care in the nephrology
community
Nephrologists’ opinions regarding dialysis withdrawal are
also quite different within and across countries.46 In
Taiwan, the nephrology community still lacks clinical
practice guidelines addressing when and how to initiate
hospice care for patients with ESRD. Many nephrologists are
not well-versed or familiar with hospice care. Some doctors
view dialysis withdrawal as a sign of treatment failure,
whereas others are uncomfortable discussing these issues
with patients and families. During renal fellowship training,
physicians should be educated about the ethical and
legal obligations of foregoing life-sustaining treatments,
making an ACP, outcomes prediction, recognition of
594 C.-F. Lai et al.candidates, execution of dialysis withholding or with-
drawal, and comfort care. Training to obtain effective
communication skills is needed to achieve effective dis-
cussion. It has been documented that developing and
teaching clinical recommendations in these issues can
improve nephrologists’ preparedness and practice in hos-
pice care.47,48Recommendations for hospice care in patients
with ESRD
ACP for chronic kidney disease and dialysis
population
Education on the concept of hospice care for the chronic
kidney disease (CKD) population should be offered as early
in the disease course as possible; this is needed for early
incorporation of a palliative care at the beginning of the
patient’s kidney disease care. ACP is a dynamic process of
communication among patients, families, and health-care
providers about the kind of care/preferences that should
be considered appropriate as decline progresses and end-
of-life issues become more prominent.49 All of the ACP,
designation of a health-care proxy or surrogate decision
maker, issuing the DNR order, and specific advance di-
rectives are important to discuss and issue while the pa-
tient has full decisional capacity.49,50 Patients’ preferences
for initiating, withholding, or withdrawing dialysis should
also be discussed. There are some recommended open
questions that may be helpful for discussing ACP with pa-
tients.51 Health-care providers should include ACP in the
comprehensive care plan for all patients. ACP is important
throughout the spectrum of renal failure and a part of
clinical practice that can be beneficial to patients and their
families.49 With the help of school education and religious
groups, concepts of thanatology, ACP, hospice care, and
organ donation should be promoted to the general popu-
lation. As mentioned previously, in Taiwan, those who are
willing to accept hospice care can electronically register
that information into the NHI IC card and could be identi-
fied in emergency.
Including nondialysis management as one of the
therapeutic options for ESRD
Dialysis may not provide life-prolonging benefits to some
elderly patients with advanced CKD.52 Recently, there has
been more recognition of, and experience with, nondialysis
medical renal therapy.53 One report from the United
Kingdom showed that elderly patients with ESRD who
choose nondialysis medical therapy can survive a substan-
tial length of time and achieve a similar number of hospital-
free days as patients who choose hemodialysis.54 Medical
management without dialysis is now viewed as an accept-
able alternative that may better help achieve patients’
goals in care.51,53 The nationwide multidisciplinary care
program (MDCP) for CKD in Taiwan proposed a standard
care protocol and annual reporting system. Evidence
showed that the MDCP improved care quality, decreased
service utilization, saved medical costs, reduced incidentdialysis patients, and decreased mortality in late-stage CKD
patients.17,55,56 Nondialysis medical therapy was also
incorporated into the Taiwan MDCP for CKD. In addition to
hemodialysis, peritoneal dialysis, and kidney transplant,
conservative nondialysis management is included as the
fourth therapeutic option for ESRD.17,57Identifying patients with ESRD who may benefit
from dialysis withdrawal
It has been reported that dialysis withdrawal is more likely
to be suggested by physicians than patients or patients’
relatives.19 It is the responsibility of nephrologists to make
suggestions about withholding or withdrawing dialysis. An
inherent aspect of hospice care is the identification of pa-
tients who may benefit from dialysis withdrawal. Physicians
should evaluate a patient’s overall condition comprehen-
sively, predict the outcome carefully, and determine the
potential effects of dialysis.
Previous reports reveal that patients at the time of
dialysis withdrawal have poor functional status, dementia,
weight loss, failure to thrive, and multiple comorbid-
ities.3,19,20,45,58,59 In these situations, doctors, patients,
and families were most likely to accept forgoing dialysis.
The Renal Physicians Association and the American Society
of Nephrology revised their clinical practice guidelines,
Shared Decision-Making in the Appropriate Initiation of
and Withdrawal from Dialysis, 2nd edition, in 2010.51 It
provides evidence-based recommendations about with-
holding and withdrawing dialysis. In these guidelines, the
following categories of patients should be considered for
withholding or withdrawing dialysis:
(1) Patients whose medical condition precludes the tech-
nical process of dialysis, including patients with
advanced dementia or mental disability who pull out
dialysis needles.
(2) Patients with conditions that are too unstable for safe
dialysis, such as when there is profound hypotension.
(3) Patients who have a terminal illness from nonrenal
causes, such as terminal cancer, end-stage lung, liver,
or heart disease, or irreversible neurological impair-
ment such as lacking signs of thought, sensation, pur-
poseful behavior, and awareness of the self and
environment.
(4) CKD or ESRD patients older than 75 years who meet two
or more of the following characteristics: short life
expectancy (“No” to the “surprise question”: would
I be surprised if this patient died in the next 6e12
months?),59,60 high comorbidity scores (modified
Charlson Comorbidity Index  8),61 marked functional
impairment (Karnofsky Performance Status score <40),
and severe chronic malnutrition (serum albumin level
2.5 g/dL). This criterion is supported by a recent
study showing that the life expectancy after dialysis
initiation for the 25th percentile of patients older than
75 years (the frail dialysis phenotype) is 0.5 years.62
We suggest that every patient with advanced CKD or
under long-term dialysis be assessed with the Charlson
Dialysis withdrawal in Taiwan 595Comorbidity Index,61 Karnofsky Performance Status score,63
and pain scores. Routinely used tools such as the 36-item
Short-Form Health Survey Questionnaire or the Short Form
of the Kidney Disease Quality of Life could be applied
to evaluate a patient’s quality of life.64,65 The “surprise
question” has been confirmed as an effective tool to
identify dialysis patients who have high early mortality59,60
and should be included. Recently, a five-item scoring tool,
including the surprise question, serum albumin level, age,
presence of peripheral vascular disease, and dementia, has
been developed and validated for the hemodialysis popu-
lation in the United States to predict 6-month mortality.59
There is also an online tool for predicting survival in he-
modialysis patients (http://touchcalc.com/calculators/
sq).
So far no validated prognostic model has been confirmed
for the dialysis population in Taiwan. We suggest using
several of the aforementioned methods to assess patients
with ESRD at initial admission or in outpatient dialysis.
Because a patient’s condition always changes with time,
regularly scheduled prognostic evaluation should be
considered. Among those patients who have a life expec-
tancy of 6 months or less and who have very poor functional
status, withdrawal and hospice options should be surveyed.
The national database systemsdthe Taiwan Renal Registry
Systemdcan serve as a suitable platform to record and
update the information regularly.9 It will help the govern-
ment to analyze statistics and make health policies
regarding hospice care in the dialysis population.Clinical approach to dialysis withdrawal
A sequential approach to dialysis withdrawal for potential
candidates involves the following:
1. Assessment of the patient’s competence. Evaluate the
patient’s cognitive function to identify whether
the patient has the capacity to make decisions.
Competence should be assessed by the ability to make a
consistent choice, an understanding and appreciation
of the consequences, and the ability to reason ratio-
nally about the decision.66
2. Identification of advance directives. Many patients lack
decision-making capacities because of dementia,
depression, or other severe neurological impairment.
Medical teams should look for the presence of previ-
ously completed advance directives, health-care prox-
ies, DNR, or physician orders for life-sustaining
treatment.
3. Assessment of possible reversible factors. Evaluate and
modify any treatable condition or symptom that moti-
vates withdrawal. Dialysis withdrawal may be reques-
ted by patients or families due to chronic debility,
repeat dialysis access failure, unremediable pain,
repeated painful needle insertions at the start of dial-
ysis, or intradialytic muscle cramps. It is not necessary
for patients with treatable depression or those experi-
encing undue social or family pressure to undergo
dialysis withdrawal.
4. Interdisciplinary team approach. Form a renal care
team and discuss with them to clarify whether dialysiswithdrawal is an option for the patient. It is better to
include nephrologists, primary care physicians, other
specialists, nurses, clinical psychologists, social
workers, dietitians, ethicists, and chaplains. This team
is also responsible for managing the medical decisions
after they are made.
5. Shared decision-making. Start a conversation to discuss
symptoms, quality of life on dialysis, goals, and prefer-
ences for care with the patient and family.51,67 A family
meeting that unites patients and family members with
their health-care teams is often needed. The four-topic
method (indications for intervention, patient prefer-
ence, quality of life, and contextual features) can be
consulted to address the main components for discus-
sion.68 The renal care team needs to ensure that the
patient and his or her family fully comprehend the de-
cision and its associated consequences. Decision making
is a consensus-building process. It may be very difficult
and is always time consuming. When there is a family
dispute, the physician’s suggestion of withdrawing dial-
ysis is always declined.40 It is important to resolve con-
flicts and disagreements between family members.51
6. Simultaneous care model. There are some patient-,
physician-, and systemic-related factors contributing to
continuing dialysis despite a dismal prognosis.6 For
those who decide to receive further dialysis, apply a
simultaneous care model: the palliative care principles
are simultaneously offered in conjunction with other
curative, life-prolonging therapies.69 Re-evaluate the
patients as disease trajectory progresses and adjust
the intensities of curative or palliative therapies
accordingly.
7. Time-limited trial of dialysis. For those who are not
making decisions yet, or those who have some uncer-
tainty about the possibility of short-term benefits from
dialysis, it is reasonable to undergo a time-limited trial
of dialysis.70 Physicians should follow-up regarding the
impact of dialysis treatments on the patient’s physical
conditions, functional status, psychosocial status, and
quality of life. After a prespecified period, such as 1 or
3 months, the burdens and benefits of dialysis should be
re-evaluated.
8. Withdrawing dialysis. Once the decision to withdraw
dialysis has been made, hospice referral for hospital
services and outpatient care is appropriate. A post-
withdrawal care plan should be mapped out with the
patient and his/her family. The preferred site of death,
persons they desire to be present, and funeral ar-
rangements should be discussed. The ACP should be
documented if it has not been completed. Informed
consent and issuing a DNR order are also needed. At an
appropriate time, terminate the dialysis treatment.
Comfort care during the postwithdrawal period
Reports from the United States show that dying patients
with ESRD use hospice care only approximately half as often
as dying patients overall.20,71 Those who are older, white,
or have failure to thrive as the reason for dialysis with-
drawal are more likely to use hospice care after dialysis
withdrawal.20 Physicians should make every effort to help
the patient have a peaceful and pain-free death,
BereavementDeath
Figure 2 Clinical approaches to withhold or withdraw dialysis in Taiwan. AKI Z acute kidney injury; CKD Z chronic kidney
disease; ESRD Z end-stage renal disease; RRT Z renal replacement therapy.
596 C.-F. Lai et al.particularly at home with family members present. A
referral to hospice care services should be offered.
After dialysis withdrawal, the median survival is 8e10
days.19,45 Providing patients with a good death after with-
drawing dialysis is an important task. The commonly re-
ported symptoms at postwithdrawal period are pain,
agitation, dyspnea, anxiety, myoclonus, fever, edema,
pruritus, diarrhea, dysphagia, and nausea.45,72 There are
clinical guidelines and suggestions for managing these
troubling symptoms.5,72e74 If necessary, one or more ses-
sions of ultrafiltration therapy may be arranged to remove
excess fluid. Under adequate hospice care, most symptoms
can be controlled to an acceptable level.45 It is also impor-
tant to offer psychosocial, religious, and spiritual support to
the patient and his/her family. The family should be assistedduring their coping and grieving and informed about avail-
able bereavement services. The continued availability of
the physician and/or other medical staff should be rein-
forced until the patient has died. To better accomplish these
tasks, a local, community-based hospice care and home care
system should be expanded upon in Taiwan.26,30Major differences between Taiwan and Western
countries
Compared with the clinical practice guidelines followed
in Western countries,51 there are some unique consider-
ations in Taiwan that need to be emphasized. First,
the physicianefamily relationship is as important as the
Dialysis withdrawal in Taiwan 597physicianepatient relationship. Including family members
in the shared decision-making process is required.35,36,40
Second, in Taiwan, there is no validated model to
estimate the prognosis specific to a dialysis patient’s
overall condition. Third, patients with irreversible, pro-
found neurological impairment but without ACP or life-
threatening complications are not included in the provi-
sional criteria of hospice care (Table 2). Similarly, without
encountering life-threatening conditions, we do not with-
draw long-term dialysis from elderly patients due to
advanced dementia, “No” to the “surprise question,” high
comorbidity scores, marked functional impairment, or se-
vere chronic malnutrition. Fourth, hospice care for acute
renal failure is indicated in those who have received renal
replacement therapy (Table 2). Decisions to not initiate
dialysis in patients with acute renal failure are made for
nonrenal causes. Finally, chronic dialysis is a “catastrophic
illness” in the Taiwan NHI. Patients with the catastrophic
illness certification who get medical care for the related
conditions do not need to pay the co-payment. Screening
hospice needs during the certificate application is a po-
tential systematic approach to improve renal hospice
care.26Research recommendations
We suggest the following issues for further research:
C Develop and validate a prognostic model to predict
short-term mortality of dialysis patients in Taiwan.
C Evaluate all dialysis patients regularly by a hospice
care screening tool. Identify a proper cut-off value
(range) to launch processes for ACP institution or
dialysis withdrawing.
C Prospectively compare the quality of life, quality of
death, and family satisfaction between dialysis with-
drawal and dialysis continuation groups.
C Impact of dialysis withdrawal on service utilization and
medical costs.Conclusion
Dialysis withdrawal is ethically beneficial to some patients
with multiple comorbidities, high symptom burden, and a
shortened life expectancy. There are cross-cultural differ-
ences relating to dialysis withdrawal between Taiwan and
the Western countries. Taiwan has the highest prevalence
of dialysis patients in the world, as well as laws and health
policies supporting hospice care and a unique culture
affecting the clinical practice of hospice care. We have
proposed recommendations and a clinical approach to
dialysis withdrawal and hospice care for patients with
advanced renal failure in Taiwan (Fig. 2). Educating pa-
tients and health-care providers, recognizing patients who
may benefit from dialysis withdrawal, organizing interdis-
ciplinary assessments, performing shared decision-making
processes, and building up a community-based hospice
care system are all warranted.Acknowledgments
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